Literature DB >> 25210086

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

B Escudier1, C Porta2, M Schmidinger3, F Algaba4, J J Patard5, V Khoo6, T Eisen7, A Horwich8.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25210086     DOI: 10.1093/annonc/mdu259

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  134 in total

Review 1.  Contemporary Status of Percutaneous Ablation for the Small Renal Mass.

Authors:  Benjamin J Shin; Jeffrey Forris Beecham Chick; S William Stavropoulos
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

2.  Outcome of radiofrequency ablation over partial nephrectomy for small renal mass (<4 cm): a systematic review and meta-analysis.

Authors:  Yue Yang; Shouzhen Chen; Fan Chen; Kejia Zhu; Qiming Deng; Li Luo; Benkang Shi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4).

Authors:  R J Motzer; A Alyasova; D Ye; A Karpenko; H Li; B Alekseev; L Xie; G Kurteva; R Kowalyszyn; O Karyakin; Y Neron; T Cosgriff; L Collins; T Brechenmacher; C Lin; L Morgan; L Yang
Journal:  Ann Oncol       Date:  2015-12-17       Impact factor: 32.976

Review 4.  PET imaging in renal cancer.

Authors:  Liza Lindenberg; Esther Mena; Peter L Choyke; Kirsten Bouchelouche
Journal:  Curr Opin Oncol       Date:  2019-05       Impact factor: 3.645

5.  Urological cancer: towards rational post-nephrectomy follow-up guidelines in RCC.

Authors:  Jean-Jacques Patard; Bernard Escudier
Journal:  Nat Rev Clin Oncol       Date:  2015-02-10       Impact factor: 66.675

6.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

7.  A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma.

Authors:  Guozhu Xie; Di Gu; Lanfang Zhang; Shijun Chen; Dehua Wu
Journal:  Cancer Biol Ther       Date:  2017-06-30       Impact factor: 4.742

8.  MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma.

Authors:  Feng Liu; Linfeng Wu; Anping Wang; Yajun Xu; Xiaodong Luo; Xing Liu; Yi Hua; Deying Zhang; Shengde Wu; Tao Lin; Dawei He; Guanghui Wei; Shanwen Chen
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 9.  Check point inhibitors a new era in renal cell carcinoma treatment.

Authors:  Mohamed Alsharedi; Heather Katz
Journal:  Med Oncol       Date:  2018-05-04       Impact factor: 3.064

Review 10.  Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.

Authors:  Alessia Mennitto; Paolo Grassi; Raffaele Ratta; Elena Verzoni; Michele Prisciandaro; Giuseppe Procopio
Journal:  Ther Adv Urol       Date:  2016-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.